Skip to main content
OpenTrials

Clinical trial condition

Advanced Solid Tumors

Explore clinical trials studying Advanced Solid Tumors. Study availability and eligibility vary by location and protocol.

631 public trials 195 recruiting studies
Refine in advanced search Browse all conditions

Advanced Solid Tumors trial results

Recruiting

A Study of JNJ-87890387 for Advanced Solid Tumors

NCT06178614

Conditions
Advanced Solid Tumors, Neoplasms
Locations
  • Start Midwest Grand Rapids, Michigan, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • Centre Leon Berard Lyon, France
  • Institut Gustave Roussy Villejuif, France
View Trial Details
Recruiting

A Study of DXC006 in Patients With Advanced Solid Tumors and Hematologic Malignancies

NCT06224855

Conditions
Advanced Solid Tumors, Hematologic Diseases, Hematologic Neoplasms, +4 more
Locations
  • Anhui Cancer Hospital Hefei, Anhui, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • Hunan Cancer Hospital Changsha, Hunan, China
  • The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
View Trial Details
Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

NCT06004245

Conditions
Advanced Solid Tumors, Colonic Diseases, Colorectal Cancer, +14 more
Locations
  • City of Hope Cancer Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • START Los Angeles Los Angeles, California, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
View all 47 locations
View Trial Details
Recruiting

First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

NCT06799065

Conditions
Adnexal Diseases, Advanced Solid Tumors, Breast Cancer Recurrent, +24 more
Locations
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

HEAT Trial (HER2 Antibody Therapy With Lutetium-177)

NCT06824155

Conditions
Advanced Solid Tumors, HER2 Gene Mutation
Locations
  • Nepean Hospital Kingswood, New South Wales, Australia
  • Macquarie University Hospital Macquarie Park, New South Wales, Australia
  • Wollongong Hospital Wollongong, New South Wales, Australia
  • St Vincents Hospital, Melbourne Fitzroy, Victoria, Australia
View Trial Details
Recruiting

Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations

NCT06915753

Conditions
Adenocarcinoma, Advanced Solid Tumors, Carcinoma, +23 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCSF Medical Center at Mount Zion San Francisco, California, United States
  • Stanford Cancer Institute Stanford, California, United States
  • The University of Kansas Medical Center Westwood, Kansas, United States
View all 16 locations
View Trial Details
Recruiting

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

NCT07262619

Conditions
Advanced Solid Tumors, Endometrial Cancer, Endometrial Neoplasms, +21 more
Locations
  • Morristown Medical Center Morristown, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center (MSKCC) New York, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • GenesisCare North Shore (Oncology) Saint Leonards, New South Wales, Australia
View all 35 locations
View Trial Details
Recruiting

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

NCT02693535

Conditions
Advanced Solid Tumors, Blood Protein Disorders, Cardiovascular Diseases, +16 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • Cancer Treatment Centers of America-Phoenix Phoenix, Arizona, United States
  • Sutter Auburn Auburn, California, United States
  • Sutter Alta Bates Berkeley, California, United States
View all 181 locations
View Trial Details
Recruiting

Study of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

NCT07435038

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +20 more
Locations
  • Blacktown Hospital Blacktown, New South Wales, Australia
  • Scientia Clinical Research Randwick, New South Wales, Australia
  • GenesisCare St Leonards, 7 Westbourne St, St Leonards Sydney, New South Wales, Australia
  • Southern Oncology Clinical Research Unit (SOCRU) Bedford Park, South Australia, Australia
View Trial Details

Related conditions